Literature DB >> 17475862

Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection.

Laurent Verkoczy1, Bao Duong, Patrick Skog, Djemel Aït-Azzouzene, Kamal Puri, José Luis Vela, David Nemazee.   

Abstract

PI3K plays key roles in cell growth, differentiation, and survival by generating the second messenger phosphatidylinositol-(3,4,5)-trisphosphate (PIP3). PIP3 activates numerous enzymes, in part by recruiting them from the cytosol to the plasma membrane. We find that in immature B lymphocytes carrying a nonautoreactive Ag receptor, PI3K signaling suppresses RAG expression and promotes developmental progression. Inhibitors of PI3K signaling abrogate this positive selection. Furthermore, immature primary B cells from mice lacking the p85alpha regulatory subunit of PI3K suppress poorly RAG expression, undergo an exaggerated receptor editing response, and, as in BCR-ligated cells, fail to progress into the G1 phase of cell cycle. Moreover, immature B cells carrying an innocuous receptor have sustained elevation of PIP3 levels and activation of the downstream effectors phospholipase C (PLC)gamma2, Akt, and Bruton's tyrosine kinase. Of these, PLCgamma2 appears to play the most significant role in down-regulating RAG expression. It therefore appears that when the BCR of an immature B cell is ligated, PIP3 levels are reduced, PLCgamma2 activation is diminished, and receptor editing is promoted by sustained RAG expression. Taken together, our results provide evidence that PI3K signaling is an important cue required for fostering development of B cells carrying a useful BCR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475862      PMCID: PMC3777394          DOI: 10.4049/jimmunol.178.10.6332

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

Authors:  K P Lam; R Kühn; K Rajewsky
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

2.  Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation.

Authors:  C D Williams; D C Linch; M J Watts; N S Thomas
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

3.  A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.

Authors:  A L Shaffer; M S Schlissel
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

4.  A functional B cell receptor transgene allows efficient IL-7-independent maturation of B cell precursors.

Authors:  D Melamed; J A Kench; K Grabstein; A Rolink; D Nemazee
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

5.  Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest.

Authors:  D Melamed; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 6.  Initiation and processing of signals from the B cell antigen receptor.

Authors:  M Reth; J Wienands
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  BCR ligation induces receptor editing in IgM+IgD- bone marrow B cells in vitro.

Authors:  M Hertz; D Nemazee
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

8.  Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line.

Authors:  R B Dyer; N K Herzog
Journal:  Biotechniques       Date:  1995-08       Impact factor: 1.993

9.  Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex.

Authors:  R H Carter; G M Doody; J B Bolen; D T Fearon
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

10.  Autoreactive B cells in the marginal zone that express dual receptors.

Authors:  Yijin Li; Hui Li; Martin Weigert
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

View more
  58 in total

1.  Central B-cell tolerance: where selection begins.

Authors:  Roberta Pelanda; Raul M Torres
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 2.  Control systems and decision making for antibody production.

Authors:  Christopher C Goodnow; Carola G Vinuesa; Katrina L Randall; Fabienne Mackay; Robert Brink
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

Review 3.  Allelic exclusion of immunoglobulin genes: models and mechanisms.

Authors:  Christian Vettermann; Mark S Schlissel
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 4.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

5.  Foxo3 Promotes Apoptosis of B Cell Receptor-Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing.

Authors:  Kristina Ottens; Rochelle M Hinman; Evan Barrios; Brian Skaug; Laurie S Davis; Quan-Zhen Li; Diego H Castrillon; Anne B Satterthwaite
Journal:  J Immunol       Date:  2018-06-27       Impact factor: 5.422

6.  Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.

Authors:  Cecille D Browne; Christopher J Del Nagro; Matthew H Cato; Hart S Dengler; Robert C Rickert
Journal:  Immunity       Date:  2009-11-05       Impact factor: 31.745

7.  Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies.

Authors:  Lenka S Teodorovic; Chiara Babolin; Sarah L Rowland; Sarah A Greaves; David P Baldwin; Raul M Torres; Roberta Pelanda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

Review 8.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 9.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

Review 10.  Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity?

Authors:  Roberta Pelanda
Journal:  Curr Opin Immunol       Date:  2014-02-15       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.